Explore Peptides and GLP-1's for Improved Weight Loss, Recovery & Performance

Does Insurance Cover GLP-1s for Weight Loss? (2026 Guide)

Home › GLP-1 clinics › Does Insurance Cover GLP-1s for Weight Loss? (2026 Guide)

Quick answer: It depends on your plan. About a third of employers cover GLP-1s for weight loss (usually with prior authorization), Medicare covers them for $50 a month through the GLP-1 Bridge (July 2026–Dec 2027) if you qualify, and only 13 state Medicaid programs covered them as of January 2026. Without coverage, self-pay prices start around $149 a month.
GLP-1 cost guideWeight loss calculatorBMI & eligibilityProtein calculator

The short version

Coverage type Does it cover Wegovy / Zepbound for weight loss?
Medicare Yes, through the Medicare GLP-1 Bridge (July 1, 2026 – Dec 31, 2027): $50 a month if you qualify. See the Medicare guide.
Medicaid Only in a minority of states — 13 as of January 2026, down from 16. See the state table below.
Employer plans Depends on your employer. Surveys in 2026 put coverage at roughly 36% of employers overall and 44–67% of large employers, almost always with prior authorization.
Type 2 diabetes, sleep apnea, heart disease Usually covered under the approved indication (e.g. Ozempic or Mounjaro for diabetes), even when weight-loss coverage is excluded.
No coverage Self-pay prices now start around $149 a month for the Wegovy pill and Foundayo and $299–$449 for Zepbound. See the cost guide.

Employer and commercial insurance

Whether your job-based plan covers GLP-1s for weight loss is a decision your employer makes. In the International Foundation of Employee Benefit Plans’ July 2026 survey, 36% of employers covered GLP-1s for both diabetes and weight loss (unchanged from 2025) and 60% covered them for diabetes only. Of those covering weight loss, 79% use prior authorization or other limits. Mercer found 44% of companies with 500+ employees cover obesity GLP-1s; Business Group on Health surveys of the largest employers put it at 60–67%. Some employers, including Cigna (for its own staff) and PwC, dropped coverage in 2026, and a minority plan to drop it in 2027.

Typical prior-authorization requirements

  • BMI of 30 or more, or 27 or more with a weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea).
  • Documentation of diet, exercise or a lifestyle program.
  • Re-approval after a few months showing you have lost weight (often 5% or more).
  • A preferred drug: some plans cover Wegovy but not Zepbound, or the reverse.

How to check your own coverage

  1. Call the number on your insurance card and ask: “Does my plan cover anti-obesity medications such as Wegovy, Zepbound, the Wegovy pill or Foundayo? Is prior authorization required?”
  2. Ask for the plan’s formulary and the prior-authorization criteria in writing.
  3. If it’s covered, ask your prescriber to submit prior authorization with your BMI, conditions and lifestyle history.
  4. If it’s denied, ask the plan for the written reason; you have the right to an internal appeal and, for most plans, an external review.

Medicaid coverage by state

As of January 2026, 13 state Medicaid programs covered GLP-1s for obesity, down from 16 in October 2025, as several states ended coverage to control costs. A federal agreement announced in November 2025 makes Wegovy and Zepbound available to state Medicaid programs at $245 a month, and CMS’s BALANCE model lets states opt in, so this list may change.

State Medicaid covers GLP-1s for obesity?
Delaware Yes
Kansas Yes
Minnesota Yes
Mississippi Yes
Missouri Yes
Wisconsin Yes
Tennessee Yes (added Jan 1, 2026)
North Carolina Yes (ended Oct 1, 2025; reinstated Dec 12, 2025)
Michigan Limited (severe obesity only)
Virginia Limited (BMI over 40, or over 37 with a related condition)
Utah Limited (pilot program funded for fiscal 2026)
Massachusetts Yes, but the governor’s proposed budget would end it
Rhode Island Yes, but the governor has proposed ending it
California (Medi-Cal) No (ended Jan 1, 2026)
New Hampshire No (ended Jan 1, 2026)
Pennsylvania No for adults 21+ (ended Jan 1, 2026)
South Carolina No (ended Jan 1, 2026)
Louisiana No (legislature has debated limited coverage)
All other states No, as of January 2026

Table based on KFF data as charted by Pew Research Center (January 2026), with later updates from KFF, Stateline and state sources through April 2026. Check with your state Medicaid agency for current rules.

Medicare

Medicare Part D has historically been barred from covering drugs for weight loss alone. From July 1, 2026 through December 31, 2027, the Medicare GLP-1 Bridge covers Wegovy (injection and pill), Foundayo and the Zepbound KwikPen for weight management at a flat $50 copay per fill for people who meet BMI and health criteria. Read the full Medicare GLP-1 Bridge guide.

If you don’t have coverage

Manufacturer self-pay programs have brought cash prices down sharply: the Wegovy pill and Foundayo start at $149 a month, Wegovy injections are $349 a month (with a $199 intro price for the first two fills), and Zepbound is $299–$449. Many local clinics bundle medication with visits and labs. Compare prices in our GLP-1 cost guide or find a clinic near you.

Track fat vs. muscleBook a DEXA body composition scan near you.Paying cash? Start onlineZyndio’s physicians review your scan before anything is prescribed.Find a GLP-1 clinic near youCompare clinics in all 50 states.

Common questions

Does insurance cover Wegovy for weight loss?

Sometimes. It depends on your plan: about a third of employers cover GLP-1s for weight loss, usually with prior authorization; Medicare covers it through the GLP-1 Bridge from July 2026 to December 2027 for people who qualify; and only about 13 state Medicaid programs cover it.

Does insurance cover Zepbound?

Coverage follows the same pattern as Wegovy, but some plans prefer one drug over the other. Medicare’s GLP-1 Bridge covers only the Zepbound KwikPen, not vials. If your plan doesn’t cover it, Zepbound’s self-pay price is $299–$449 a month.

Why was my GLP-1 prior authorization denied?

Common reasons are a BMI below the plan’s cutoff, missing documentation of diet and exercise, a non-preferred drug, or a plan that excludes weight-loss drugs entirely. Ask for the denial reason in writing, then ask your prescriber about an appeal or a covered alternative.

Is Ozempic covered for weight loss?

Ozempic is approved for type 2 diabetes, so plans generally cover it only for diabetes. For weight loss, the approved semaglutide product is Wegovy.

Sources

Coverage rules change often and differ by plan. This guide summarizes public sources as of October 27, 2026 and is not insurance, legal or medical advice. Always confirm with your plan, your state Medicaid agency or Medicare (1-800-MEDICARE).